Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence. Zhen J, Chen L, Wang H, Li D, et al. J Neurooncol 2024;170:665-673.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhen J, Chen L, Wang H, Li D, et al. Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence. J Neurooncol 2024;170:665-673.
PMID: 39422814